Showing results (371-380 of 608) with videos related to

Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2022
Tolerability and Safety of Switching from Rituximab to Ocrelizumab: Evaluating Factors Associated with Infusion Related ReactionsEnrique Alvarez, Kavita V Nair, Stefan Sillau, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2022
Real-world effectiveness of dimethyl fumarate versus fingolimod in a cohort of patients with multiple sclerosis using standardized, quantitative outcome metricsCarrie M Hersh, Arman Altincatal, Nicholas Belviso, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2022
Cervical Spinal Cord Atrophy can be Accurately Quantified Using Head ImagesKamyar Taheri, Irene M Vavasour, Shawna Abel, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2022
Let's talk about sex(ual) wellbeing! Staff perceptions of implementing a novel service for people with Multiple SclerosisLaura Jarvis, Kevin McConville, Sonia Devereux, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 10, 2022
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort studyMaria Antonella Zingaropoli, Patrizia Pasculli, Marco Iannetta, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2021
Diagnostic value of gadolinium contrast administration for spinal cord magnetic resonance imaging in multiple sclerosis patients and correlative markers of lesion enhancementKianush Karimian-Jazi, Ulf Neuberger, Katharina Schregel, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2021
Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disordersVyanka Redenbaugh, Mayra Montalvo, Elia Sechi, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2021
Evaluation of short-term safety of COVID-19 vaccines in patients with multiple sclerosis from Latin AmericaRicardo Alonso, Aníbal Chertcoff, Felisa Del V Leguizamón, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 20, 2022
Cerebrospinal fluid evaluation in patients with progressive motor impairment due to critical central nervous system demyelinating lesionsBenan Barakat, Steve Messina, Shreya Nayak, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 17, 2021
Feasibility of cognitive rehabilitation in patients with advanced multiple sclerosis: A pilot studyStefanos E Prouskas, Nancy D Chiaravalloti, Neeltje Kant, et al.
Pageof 61